Tuesday, January 24, 2012

Biocon's Nine-Month Revenues Driven by Growth in Branded Formulations ... - Moneylife Personal Finance site and magazine

Biocon's Nine-Month Revenues Driven by Growth in Branded Formulations ... Moneylife Personal Finance site and magazine Announced Positive effectiveness Data on Novel being Antibody, Itolizumab in crucial Phase 3 Psoriasis examination in India. -- booming launch of INSUPen®, AN innovative delivery device for Insulin and analogs facultative us to comprehensively grow the ... Link To Article

No comments:

Post a Comment